Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Horne

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Medicine|September 16, 2020
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical EvidenceSalihanur Darici, Hazem Alkhaldi, Gillian Horne, et al.
Cardiovascular and Interventional Radiology|August 22, 2007
Early results of endovascular treatment of the thoracic aorta using the Valiant endograftMatt Thompson, Stella Ivaz, Nicholas Cheshire, et al.
Palliative Care and Social Practice|December 4, 2023
Engaging with communities in rural, coastal and low-income areas to understand barriers to palliative care and bereavement support: reflections on a community engagement programme in South-west EnglandLorraine Hansford, Katrina Wyatt, Siobhan Creanor, et al.
The Lancet. Haematology|December 15, 2021
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trialMhairi Copland, Daniel Slade, Graham McIlroy, et al.
Leukemia|September 19, 2024
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacyAndrew J Innes, Chloe Hayden, Victoria Orovboni, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Medicine|September 16, 2020
Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical EvidenceSalihanur Darici, Hazem Alkhaldi, Gillian Horne, et al.
Cardiovascular and Interventional Radiology|August 22, 2007
Early results of endovascular treatment of the thoracic aorta using the Valiant endograftMatt Thompson, Stella Ivaz, Nicholas Cheshire, et al.
Palliative Care and Social Practice|December 4, 2023
Engaging with communities in rural, coastal and low-income areas to understand barriers to palliative care and bereavement support: reflections on a community engagement programme in South-west EnglandLorraine Hansford, Katrina Wyatt, Siobhan Creanor, et al.
The Lancet. Haematology|December 15, 2021
Ponatinib with fludarabine, cytarabine, idarubicin, and granulocyte colony-stimulating factor chemotherapy for patients with blast-phase chronic myeloid leukaemia (MATCHPOINT): a single-arm, multicentre, phase 1/2 trialMhairi Copland, Daniel Slade, Graham McIlroy, et al.
Leukemia|September 19, 2024
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacyAndrew J Innes, Chloe Hayden, Victoria Orovboni, et al.
Pageof 2